Ideal practices of cross-linking for infectious keratitis
| Survey response | n/N (%) |
| Ideal timing* | |
| <1 week | 11/24 (46%) |
| 1–4 weeks | 9/24 (38%) |
| >4 weeks | 0/24 (0%) |
| Unsure | 4/24 (17%) |
| Ideal ulcer location for CXL* | |
| Central | 6/24 (25%) |
| Peripheral | 1/24 (4%) |
| Does not matter | 13/24 (54%) |
| Unsure | 4/24 (17%) |
| CXL beneficial by infiltrate size | |
| Small* | 17/24 (71%) |
| Medium† | 16/23 (70%) |
| Large† | 8/23 (35%) |
| Would use CXL for corneal thinning | 15/25 (60%) |
| Would use CXL for non-healing ulcer | 12/25 (48%) |
| Main benefits of CXL | |
| Microbial eradication | 21/25 (84%) |
| Prevention of corneal thinning | 15/25 (60%) |
| Other benefits | 3/25 (12%) |
*One respondent with missing data.
†Two respondents with missing data.
CXL, corneal cross-linking.